Becky J. Proskocil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Becky J. Proskocil has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Allison D. Fryer
Division of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States
12 shared publications - David B. Jacoby
Division of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States
8 shared publications - Pamela J. Lein
University of California, Davis
5 shared publications Donald A. Bruun
Department of Molecular Biosciences, University of California School of Veterinary Medicine, Davis, California
4 shared publications- Matthew Georgenson Drake
Oregon Health & Science University
4 shared publications Allison Fryer
Oregon Health and Science University, Portland, United States
3 shared publications
Latest Publications
- Open Access
- 30 March 2026
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
Optogenetic vagotomy inhibits reflex bronchoconstriction and cardiac chronotropy
Optogenetics involves genetic insertion of light-sensitive ion channels into nerves, such as with cre-based recombination. The recent increase in cre-based mouse lines has expanded our ability to test the roles of peripheral nerves in homeostasis and in disease models. Here, we generated an optogenetic mouse line in which hyperpolarizing inhibitory halorhodopsin channels were inserted into vagal cholinergic (parasympathetic) nerves using choline acetyltransferase (ChAT)-cre, enabling targeted inhibition of parasympathetic nerves. Halorhodopsin expression in parasympathetic neurons was confirmed by RT-PCR and confocal microscopy. Nerve reflex responses were generated with aerosolized serotonin or methacholine, during which mice were exposed to hyperpolarizing 645 nm or control 454 nm and 570 nm light. Inhibition of parasympathetic nerves by halorhodopsin attenuated airway hyperreactivity in house dust mite challenged mice while inhibition of cardiac cholinergic nerves increased heart rate. Our findings demonstrate the utility of halorhodopsin as a tool for testing the roles of parasympathetic nerves in cardiopulmonary function.
- 30 March 2026
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
Open AccessOptogenetic vagotomy inhibits reflex bronchoconstriction and cardiac chronotropy
Optogenetics involves genetic insertion of light-sensitive ion channels into nerves, such as with cre-based recombination. The recent increase in cre-based mouse lines has expanded our ability to test the roles of peripheral nerves in homeostasis and in disease models. Here, we generated an optogenetic mouse line in which hyperpolarizing inhibitory halorhodopsin channels were inserted into vagal cholinergic (parasympathetic) nerves using choline acetyltransferase (ChAT)-cre, enabling targeted inhibition of parasympathetic nerves. Halorhodopsin expression in parasympathetic neurons was confirmed by RT-PCR and confocal microscopy. Nerve reflex responses were generated with aerosolized serotonin or methacholine, during which mice were exposed to hyperpolarizing 645 nm or control 454 nm and 570 nm light. Inhibition of parasympathetic nerves by halorhodopsin attenuated airway hyperreactivity in house dust mite challenged mice while inhibition of cardiac cholinergic nerves increased heart rate. Our findings demonstrate the utility of halorhodopsin as a tool for testing the roles of parasympathetic nerves in cardiopulmonary function.
- Open Access
- 1 December 2024
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 327 (6) , L867-L875
Eosinophils prevent diet-induced airway hyperresponsiveness in mice on a high-fat diet
This study investigates how eosinophils influence systemic metabolism and airway function in obesity. Known for their immune functions, eosinophils also mitigate obesity-related hyperinsulinemia, reducing airway hyperresponsiveness in obese mice models. The findings suggest potential therapeutic strategies targeting the intricate interplay among neurons, eosinophils, and the endocrine system to alleviate asthma in obesity. This research provides novel insights into the critical neuro-immune-endocrine interactions essential for managing obesity-related asthma.
- 1 December 2024
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 327 (6) , L867-L875
Open AccessEosinophils prevent diet-induced airway hyperresponsiveness in mice on a high-fat diet
This study investigates how eosinophils influence systemic metabolism and airway function in obesity. Known for their immune functions, eosinophils also mitigate obesity-related hyperinsulinemia, reducing airway hyperresponsiveness in obese mice models. The findings suggest potential therapeutic strategies targeting the intricate interplay among neurons, eosinophils, and the endocrine system to alleviate asthma in obesity. This research provides novel insights into the critical neuro-immune-endocrine interactions essential for managing obesity-related asthma.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA418
The impact of adipose eosinophils on diet-induced airway hyperresponsiveness in mice
Introduction: Adipose eosinophils exhibit an obesity-resistant effect and are associated with the inhibition of high fat diet (HFD)-induced hyperinsulinemia. Additionally, reducing circulating insulin has been linked to a decrease in obesity-related airway hyperresponsiveness. Aim: To determine if adipose tissue eosinophils protect against HFD-induced airway hyperresponsiveness and metabolic dysfunction. Methods: Transgenic mice with increased circulating eosinophils due to interleukin-5 expression in T cells (+IL5T) and WT mice were fed HFD or normal chow for 19 weeks. Body weight and fat, fasting insulin and glucose, and airway responsiveness to inhaled serotonin before and after vagotomy were measured. Orexin receptor mRNA expression was measured in nodose and jugular ganglia. Airway responsiveness to serotonin was also measured following acute administration of insulin to WT mice. Results: Both WT and +IL5T mice fed a HFD gained body weight and fat, however +IL5T mice gained less. WT mice, but not +IL5T mice, on HFD had significant increased fasting insulin and airway hyperresponsiveness before vagotomy. Moreover, acute insulin administration significantly increased serotonin-induced airway responsiveness in WT mice. Baseline eosinophils were increased in multiple tissues in +IL5T mice, and HFD selectively increased adipose tissue eosinophils. Orexin receptor 1 and 2 mRNA expression was decreased in +IL5T mice regardless of diet. Conclusions: The increased adipose eosinophils in +IL5T mice may mitigate hyperinsulinemia, thereby preventing airway hyperresponsiveness. Determining the mechanism of these events may aid in developing targeted therapies for obesity-related asthma.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA418
The impact of adipose eosinophils on diet-induced airway hyperresponsiveness in mice
Introduction: Adipose eosinophils exhibit an obesity-resistant effect and are associated with the inhibition of high fat diet (HFD)-induced hyperinsulinemia. Additionally, reducing circulating insulin has been linked to a decrease in obesity-related airway hyperresponsiveness. Aim: To determine if adipose tissue eosinophils protect against HFD-induced airway hyperresponsiveness and metabolic dysfunction. Methods: Transgenic mice with increased circulating eosinophils due to interleukin-5 expression in T cells (+IL5T) and WT mice were fed HFD or normal chow for 19 weeks. Body weight and fat, fasting insulin and glucose, and airway responsiveness to inhaled serotonin before and after vagotomy were measured. Orexin receptor mRNA expression was measured in nodose and jugular ganglia. Airway responsiveness to serotonin was also measured following acute administration of insulin to WT mice. Results: Both WT and +IL5T mice fed a HFD gained body weight and fat, however +IL5T mice gained less. WT mice, but not +IL5T mice, on HFD had significant increased fasting insulin and airway hyperresponsiveness before vagotomy. Moreover, acute insulin administration significantly increased serotonin-induced airway responsiveness in WT mice. Baseline eosinophils were increased in multiple tissues in +IL5T mice, and HFD selectively increased adipose tissue eosinophils. Orexin receptor 1 and 2 mRNA expression was decreased in +IL5T mice regardless of diet. Conclusions: The increased adipose eosinophils in +IL5T mice may mitigate hyperinsulinemia, thereby preventing airway hyperresponsiveness. Determining the mechanism of these events may aid in developing targeted therapies for obesity-related asthma.
- Open Access
- 1 December 2023
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 325 (6) , L776-L787
Grandmaternal allergen sensitization reprograms epigenetic and airway responses to allergen in second-generation offspring
Asthma susceptibility is influenced by environmental, genetic, and epigenetic factors. This study shows that maternal allergen exposure during pregnancy promotes unique epigenetic trajectories in second-generation offspring at baseline and in response to allergen sensitization, which is associated with the potentiation of airway hyperreactivity. These effects are one mechanism by which maternal asthma may influence the inheritance of asthma risk.
- 1 December 2023
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 325 (6) , L776-L787
Open AccessGrandmaternal allergen sensitization reprograms epigenetic and airway responses to allergen in second-generation offspring
Asthma susceptibility is influenced by environmental, genetic, and epigenetic factors. This study shows that maternal allergen exposure during pregnancy promotes unique epigenetic trajectories in second-generation offspring at baseline and in response to allergen sensitization, which is associated with the potentiation of airway hyperreactivity. These effects are one mechanism by which maternal asthma may influence the inheritance of asthma risk.
- 1 December 2021
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 321 (6) , L1105-L1118
Metformin prevents airway hyperreactivity in rats with dietary obesity
Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma.
- 1 December 2021
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 321 (6) , L1105-L1118
Metformin prevents airway hyperreactivity in rats with dietary obesity
Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma.
- 19 May 2021
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 321 (1) , L236-L247
Pioglitazone prevents obesity-related airway hyperreactivity and neuronal M2 receptor dysfunction
Obesity-related asthma often presents with more severe symptoms than non-obesity-related asthma and responds poorly to current treatments. Both insulin resistance and hyperinsulinemia are common in obesity. We have shown that increased insulin mediates airway hyperreactivity in diet-induced obese rats by causing neuronal M2 muscarinic receptor dysfunction, which normally inhibits acetylcholine release from parasympathetic nerves. Decreasing insulin with streptozotocin prevented airway hyperreactivity and M2 receptor dysfunction. The objective of the present study was to investigate whether pioglitazone, a hypoglycemic drug, prevents airway hyperreactivity and M2 receptor dysfunction in obese rats. Male rats fed a low- or high-fat diet were treated with pioglitazone or PBS by daily gavage. Body weight, body fat, fasting insulin, and bronchoconstriction and bradycardia in response to electrical stimulation of vagus nerves and to aerosolized methacholine were recorded. Pilocarpine, a muscarinic receptor agonist, was used to measure M2 receptor function. Rats on a high-fat diet had potentiated airway responsiveness to vagal stimulation and dysfunctional neuronal M2 receptors, whereas airway responsiveness to methacholine was unaffected. Pioglitazone reduced fasting insulin and prevented airway hyperresponsiveness and M2 receptor dysfunction but did not change inflammatory cytokine mRNA expression in alveolar macrophages. High-fat diet, with and without pioglitazone, had tissue-specific effects on insulin receptor mRNA expression. In conclusion, pioglitazone prevents vagally mediated airway hyperreactivity and protects neuronal M2 muscarinic receptor function in obese rats.
- 19 May 2021
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 321 (1) , L236-L247
Pioglitazone prevents obesity-related airway hyperreactivity and neuronal M2 receptor dysfunction
Obesity-related asthma often presents with more severe symptoms than non-obesity-related asthma and responds poorly to current treatments. Both insulin resistance and hyperinsulinemia are common in obesity. We have shown that increased insulin mediates airway hyperreactivity in diet-induced obese rats by causing neuronal M2 muscarinic receptor dysfunction, which normally inhibits acetylcholine release from parasympathetic nerves. Decreasing insulin with streptozotocin prevented airway hyperreactivity and M2 receptor dysfunction. The objective of the present study was to investigate whether pioglitazone, a hypoglycemic drug, prevents airway hyperreactivity and M2 receptor dysfunction in obese rats. Male rats fed a low- or high-fat diet were treated with pioglitazone or PBS by daily gavage. Body weight, body fat, fasting insulin, and bronchoconstriction and bradycardia in response to electrical stimulation of vagus nerves and to aerosolized methacholine were recorded. Pilocarpine, a muscarinic receptor agonist, was used to measure M2 receptor function. Rats on a high-fat diet had potentiated airway responsiveness to vagal stimulation and dysfunctional neuronal M2 receptors, whereas airway responsiveness to methacholine was unaffected. Pioglitazone reduced fasting insulin and prevented airway hyperresponsiveness and M2 receptor dysfunction but did not change inflammatory cytokine mRNA expression in alveolar macrophages. High-fat diet, with and without pioglitazone, had tissue-specific effects on insulin receptor mRNA expression. In conclusion, pioglitazone prevents vagally mediated airway hyperreactivity and protects neuronal M2 muscarinic receptor function in obese rats.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Macrophages in lung and innervating ganglia express TLR7 and release nitric oxide
Background: Toll-like receptor 7 (TLR7) detects RNA viruses and triggers an innate immune response. TLR7 imidazoquinoline agonists bronchodilate airways via release of nitric oxide. TLR7 expression has been reported in airway epithelium and nerves, however lack of antibody specificity questioned these results. Objective: To determine TLR7 expression in airways using immunohistochemistry and RNAscope in situ hybridization and to determine the source of TLR7-induced nitric oxide. Methods: A published TLR7 antibody and species specific TLR7 RNAscope probes (Advanced Cell Diagnostics) were tested in wild type (WT) mice, TLR7 knock out (KO) mice, and guinea pigs. The identity of TLR7-positive cells was further determined by immunohistochemistry. Cultured sensory ganglia were loaded with a fluorescent nitric oxide indicator and treated with the TLR7 agonist R837. Results: TLR7 RNA was detected in WT mouse and guinea pig alveolar macrophages and in macrophages adjacent to neurons in sensory ganglia and parasympathetic ganglia. TLR7 RNA was absent in neurons. RNAscope probes did not detect TLR7 RNA in TLR7 KO mice. In contrast, TLR7 antibody labeled airway nerves and epithelium in WT and TLR7 KO mice and in guinea pigs. Notably, TLR7 RNAscope probes and antibody labeled distinctly different cells. In cultured ganglia, TLR7 agonist R837 significantly increased nitric oxide in macrophages and support cells, but not in neurons. Conclusion: TLR7 is expressed by lung macrophages, supporting their antiviral role. Macrophages are a source of TLR7-induced nitric oxide. The difference in TLR7 expression using RNAscope probes versus the antibody challenges previous reports of airway TLR7 expression.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Macrophages in lung and innervating ganglia express TLR7 and release nitric oxide
Background: Toll-like receptor 7 (TLR7) detects RNA viruses and triggers an innate immune response. TLR7 imidazoquinoline agonists bronchodilate airways via release of nitric oxide. TLR7 expression has been reported in airway epithelium and nerves, however lack of antibody specificity questioned these results. Objective: To determine TLR7 expression in airways using immunohistochemistry and RNAscope in situ hybridization and to determine the source of TLR7-induced nitric oxide. Methods: A published TLR7 antibody and species specific TLR7 RNAscope probes (Advanced Cell Diagnostics) were tested in wild type (WT) mice, TLR7 knock out (KO) mice, and guinea pigs. The identity of TLR7-positive cells was further determined by immunohistochemistry. Cultured sensory ganglia were loaded with a fluorescent nitric oxide indicator and treated with the TLR7 agonist R837. Results: TLR7 RNA was detected in WT mouse and guinea pig alveolar macrophages and in macrophages adjacent to neurons in sensory ganglia and parasympathetic ganglia. TLR7 RNA was absent in neurons. RNAscope probes did not detect TLR7 RNA in TLR7 KO mice. In contrast, TLR7 antibody labeled airway nerves and epithelium in WT and TLR7 KO mice and in guinea pigs. Notably, TLR7 RNAscope probes and antibody labeled distinctly different cells. In cultured ganglia, TLR7 agonist R837 significantly increased nitric oxide in macrophages and support cells, but not in neurons. Conclusion: TLR7 is expressed by lung macrophages, supporting their antiviral role. Macrophages are a source of TLR7-induced nitric oxide. The difference in TLR7 expression using RNAscope probes versus the antibody challenges previous reports of airway TLR7 expression.
- 1 November 2019
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 61 (5) , 620-630
Organophosphorus Pesticides Induce Cytokine Release from Differentiated Human THP1 Cells
Epidemiologic studies link organophosphorus pesticides (OPs) to increased incidence of asthma. In guinea pigs, OP-induced airway hyperreactivity requires macrophages and TNF-α. Here, we determined whether OPs interact directly with macrophages to alter cytokine expression or release. Human THP1 cells were differentiated into macrophages and then exposed to parathion, chlorpyrifos, or diazinon, or their oxon, phosphate, or phosphorothioate metabolites for 24 hours in the absence or presence of reagents that block cholinergic receptors. TNF-α, IL-1β, platelet-derived growth factor, and transforming growth factor-β mRNA and protein were quantified by qPCR and ELISA, respectively. The effects of OPs on NF-κB, acetylcholinesterase, and intracellular calcium were also measured. Parent OPs and their oxon metabolites upregulated cytokine mRNA and stimulated cytokine release. TNF-α release, which was the most robust response, was triggered by parent, but not oxon, compounds. Cytokine expression was also increased by diethyl dithiophosphate but not diethyl thiophosphate or diethyl phosphate metabolites. Parent OPs, but not oxon metabolites, activated NF-κB. Parent and oxon metabolites decreased acetylcholinesterase activity, but comparable acetylcholinesterase inhibition by eserine did not mimic OP effects on cytokines. Consistent with the noncholinergic mechanisms of OP effects on macrophages, pharmacologic antagonism of muscarinic or nicotinic receptors did not prevent OP-induced cytokine expression or release. These data indicate that phosphorothioate OP compounds directly stimulate macrophages to release TNF-α, potentially via activation of NF-κB, and suggest that therapies that target NF-κB may prevent OP-induced airway hyperreactivity.
- 1 November 2019
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 61 (5) , 620-630
Organophosphorus Pesticides Induce Cytokine Release from Differentiated Human THP1 Cells
Epidemiologic studies link organophosphorus pesticides (OPs) to increased incidence of asthma. In guinea pigs, OP-induced airway hyperreactivity requires macrophages and TNF-α. Here, we determined whether OPs interact directly with macrophages to alter cytokine expression or release. Human THP1 cells were differentiated into macrophages and then exposed to parathion, chlorpyrifos, or diazinon, or their oxon, phosphate, or phosphorothioate metabolites for 24 hours in the absence or presence of reagents that block cholinergic receptors. TNF-α, IL-1β, platelet-derived growth factor, and transforming growth factor-β mRNA and protein were quantified by qPCR and ELISA, respectively. The effects of OPs on NF-κB, acetylcholinesterase, and intracellular calcium were also measured. Parent OPs and their oxon metabolites upregulated cytokine mRNA and stimulated cytokine release. TNF-α release, which was the most robust response, was triggered by parent, but not oxon, compounds. Cytokine expression was also increased by diethyl dithiophosphate but not diethyl thiophosphate or diethyl phosphate metabolites. Parent OPs, but not oxon metabolites, activated NF-κB. Parent and oxon metabolites decreased acetylcholinesterase activity, but comparable acetylcholinesterase inhibition by eserine did not mimic OP effects on cytokines. Consistent with the noncholinergic mechanisms of OP effects on macrophages, pharmacologic antagonism of muscarinic or nicotinic receptors did not prevent OP-induced cytokine expression or release. These data indicate that phosphorothioate OP compounds directly stimulate macrophages to release TNF-α, potentially via activation of NF-κB, and suggest that therapies that target NF-κB may prevent OP-induced airway hyperreactivity.
- 28 September 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 54 (suppl 63) , PA3883
TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists
Background: Toll-like receptor 7 (TLR7) imidazoquinoline agonists bronchodilate guinea pig and human airways partly via nitric oxide production. Aim: To define airway TLR7 expression and the mechanism of TLR7 agonist-mediated bronchodilation. Methods: Guinea pig airways were suspended in Krebs in an organ bath, contracted (MCh, 3µM) and treated with TLR7 agonist R837 (10-300µM). Some airways were pre-treated with tetrodotoxin (TTX; 1µM) or tested in calcium-free Krebs. TLR7 expression was assessed using RNAScope in situ hybridization followed by immunohistochemistry for neurons (PGP9.5). Separately, cultured airway smooth muscle and sensory ganglia loaded with a fluorescent nitric oxide (NO-ON) or calcium indicator (Fluo-4-AM) were treated with R837 (30-100µM) and imaged by confocal microscopy. Results: TLR7 agonist R837 relaxed precontracted airways. R837-mediated relaxation was unaffected by TTX or by the absence of extracellular calcium. TLR7 was expressed in satellite glial cells (Fig. 1, arrows), but not airway neurons or smooth muscle. R837 increased nitric oxide in satellite cells, but not in neurons or smooth muscle, whereas R837 increased intracellular calcium in neurons, smooth muscle and satellite cells. Conclusions: TLR7 agonists relax airways via satellite cell nitric oxide release and possibly TLR7-independent effects on smooth muscle calcium. TLR7 agonists are potential bronchodilators for human development.
- 28 September 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 54 (suppl 63) , PA3883
TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists
Background: Toll-like receptor 7 (TLR7) imidazoquinoline agonists bronchodilate guinea pig and human airways partly via nitric oxide production. Aim: To define airway TLR7 expression and the mechanism of TLR7 agonist-mediated bronchodilation. Methods: Guinea pig airways were suspended in Krebs in an organ bath, contracted (MCh, 3µM) and treated with TLR7 agonist R837 (10-300µM). Some airways were pre-treated with tetrodotoxin (TTX; 1µM) or tested in calcium-free Krebs. TLR7 expression was assessed using RNAScope in situ hybridization followed by immunohistochemistry for neurons (PGP9.5). Separately, cultured airway smooth muscle and sensory ganglia loaded with a fluorescent nitric oxide (NO-ON) or calcium indicator (Fluo-4-AM) were treated with R837 (30-100µM) and imaged by confocal microscopy. Results: TLR7 agonist R837 relaxed precontracted airways. R837-mediated relaxation was unaffected by TTX or by the absence of extracellular calcium. TLR7 was expressed in satellite glial cells (Fig. 1, arrows), but not airway neurons or smooth muscle. R837 increased nitric oxide in satellite cells, but not in neurons or smooth muscle, whereas R837 increased intracellular calcium in neurons, smooth muscle and satellite cells. Conclusions: TLR7 agonists relax airways via satellite cell nitric oxide release and possibly TLR7-independent effects on smooth muscle calcium. TLR7 agonists are potential bronchodilators for human development.
- 1 September 2016
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 55 (3) , 387-394
Human and Mouse Eosinophils Have Antiviral Activity against Parainfluenza Virus
Respiratory viruses cause asthma exacerbations. Because eosinophils are the prominent leukocytes in the airways of 60–70% of patients with asthma, we evaluated the effects of eosinophils on a common respiratory virus, parainfluenza 1, in the lung. Eosinophils recruited to the airways of wild-type mice after ovalbumin sensitization and challenge significantly decreased parainfluenza virus RNA in the lungs 4 days after infection compared with nonsensitized animals. This antiviral effect was also seen in IL-5 transgenic mice with an abundance of airway eosinophils (NJ.1726) but was lost in transgenic eosinophil-deficient mice (PHIL) and in IL-5 transgenic mice crossed with eosinophil-deficient mice (NJ.1726-PHIL). Loss of the eosinophil granule protein eosinophil peroxidase, using eosinophil peroxidase–deficient transgenic mice, did not reduce eosinophils’ antiviral effect. Eosinophil antiviral mechanisms were also explored in vitro. Isolated human eosinophils significantly reduced parainfluenza virus titers. This effect did not involve degradation of viral RNA by eosinophil granule RNases. However, eosinophils treated with a nitric oxide synthase inhibitor lost their antiviral activity, suggesting eosinophils attenuate viral infectivity through production of nitric oxide. Consequently, eosinophil nitric oxide production was measured with an intracellular fluorescent probe. Eosinophils produced nitric oxide in response to virus and to a synthetic agonist of the virus-sensing innate immune receptor, Toll-like receptor (TLR) 7. IFNγ increased expression of eosinophil TLR7 and potentiated TLR7-induced nitric oxide production. These results suggest that eosinophils promote viral clearance in the lung and contribute to innate immune responses against respiratory virus infections in humans.
- 1 September 2016
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 55 (3) , 387-394
Human and Mouse Eosinophils Have Antiviral Activity against Parainfluenza Virus
Respiratory viruses cause asthma exacerbations. Because eosinophils are the prominent leukocytes in the airways of 60–70% of patients with asthma, we evaluated the effects of eosinophils on a common respiratory virus, parainfluenza 1, in the lung. Eosinophils recruited to the airways of wild-type mice after ovalbumin sensitization and challenge significantly decreased parainfluenza virus RNA in the lungs 4 days after infection compared with nonsensitized animals. This antiviral effect was also seen in IL-5 transgenic mice with an abundance of airway eosinophils (NJ.1726) but was lost in transgenic eosinophil-deficient mice (PHIL) and in IL-5 transgenic mice crossed with eosinophil-deficient mice (NJ.1726-PHIL). Loss of the eosinophil granule protein eosinophil peroxidase, using eosinophil peroxidase–deficient transgenic mice, did not reduce eosinophils’ antiviral effect. Eosinophil antiviral mechanisms were also explored in vitro. Isolated human eosinophils significantly reduced parainfluenza virus titers. This effect did not involve degradation of viral RNA by eosinophil granule RNases. However, eosinophils treated with a nitric oxide synthase inhibitor lost their antiviral activity, suggesting eosinophils attenuate viral infectivity through production of nitric oxide. Consequently, eosinophil nitric oxide production was measured with an intracellular fluorescent probe. Eosinophils produced nitric oxide in response to virus and to a synthetic agonist of the virus-sensing innate immune receptor, Toll-like receptor (TLR) 7. IFNγ increased expression of eosinophil TLR7 and potentiated TLR7-induced nitric oxide production. These results suggest that eosinophils promote viral clearance in the lung and contribute to innate immune responses against respiratory virus infections in humans.